Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Sonendo general counsel Jacqueline Collins, CTO Merhzad Khakpour to depart » 08:32
06/17/22
06/17
08:32
06/17/22
08:32
SONX

Sonendo

$2.21 /

+0.03 (+1.38%)

Sonendo announced two…

Sonendo announced two upcoming departures from its executive management team. Jacqueline Collins, vice president, general counsel, and Merhzad Khakpour, chief technology officer, will each leave the company in July for other opportunities. A search is underway for a new general counsel and a new chief technology officer with extensive experience in product development to lead and scale the R&D organization for the company's next stage of growth.

ShowHide Related Items >><<
SONX Sonendo
$2.21 /

+0.03 (+1.38%)

SONX Sonendo
$2.21 /

+0.03 (+1.38%)

06/17/22 Stifel
Sonendo price target lowered to $6 from $10 at Stifel
05/11/22 Piper Sandler
Sonendo price target lowered to $7 from $12 at Piper Sandler
03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
SONX Sonendo
$2.21 /

+0.03 (+1.38%)

  • 29
    Oct
SONX Sonendo
$2.21 /

+0.03 (+1.38%)

Recommendations
Sonendo price target lowered to $6 from $10 at Stifel » 07:24
06/17/22
06/17
07:24
06/17/22
07:24
SONX

Sonendo

/

+

Stifel analyst Jonathan…

Stifel analyst Jonathan Block lowered the firm's price target on Sonendo to $6 from $10 and keeps a Buy rating on the shares following his review of the Q1 10-Q filings for a portion of his dental coverage and adjustments to his models where appropriate.

ShowHide Related Items >><<
SONX Sonendo
/

+

SONX Sonendo
/

+

05/11/22 Piper Sandler
Sonendo price target lowered to $7 from $12 at Piper Sandler
03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
SONX Sonendo
/

+

  • 29
    Oct
SONX Sonendo
/

+

Over a month ago
Hot Stocks
Sonendo rises 19.6% » 12:00
05/16/22
05/16
12:00
05/16/22
12:00
SONX

Sonendo

$3.13 /

+0.51 (+19.47%)

Sonendo is up 19.6%, or…

Sonendo is up 19.6%, or 51c to $3.11.

ShowHide Related Items >><<
SONX Sonendo
$3.13 /

+0.51 (+19.47%)

SONX Sonendo
$3.13 /

+0.51 (+19.47%)

05/11/22 Piper Sandler
Sonendo price target lowered to $7 from $12 at Piper Sandler
03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
SONX Sonendo
$3.13 /

+0.51 (+19.47%)

  • 29
    Oct
SONX Sonendo
$3.13 /

+0.51 (+19.47%)

Recommendations
Sonendo price target lowered to $7 from $12 at Piper Sandler » 04:46
05/11/22
05/11
04:46
05/11/22
04:46
SONX

Sonendo

$2.70 /

+0.1 (+3.85%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar lowered the firm's price target on Sonendo to $7 from $12 and keeps an Overweight rating on the shares post the Q1 results. The commercial execution at Sonendo continues to track ahead of plan, and its path towards accelerating revenue growth makes the shares attractive in the broader environment "where visibility is severely constrained for a number of small-cap companies," Bednar tells investors in a research note. The lowered the price target to reflect contracting market and peer group multiples.

ShowHide Related Items >><<
SONX Sonendo
$2.70 /

+0.1 (+3.85%)

SONX Sonendo
$2.70 /

+0.1 (+3.85%)

03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
SONX Sonendo
$2.70 /

+0.1 (+3.85%)

  • 29
    Oct
SONX Sonendo
$2.70 /

+0.1 (+3.85%)

Earnings
Sonendo backs FY22 revenue view $40M-$43M, consensus $41.64M  16:04
05/10/22
05/10
16:04
05/10/22
16:04
SONX

Sonendo

$2.78 /

+0.18 (+6.92%)

 
ShowHide Related Items >><<
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

SONX Sonendo
$2.78 /

+0.18 (+6.92%)

03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

  • 29
    Oct
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

Earnings
Sonendo reports Q1 EPS (59c), consensus (56c) » 16:04
05/10/22
05/10
16:04
05/10/22
16:04
SONX

Sonendo

$2.78 /

+0.18 (+6.92%)

Reports Q1 revenue $9M,…

Reports Q1 revenue $9M, consensus $8.22M. "We are very proud of our quarterly results and start to the year, as we continue to see strong utilization among our install base, despite the spike in Omicron infection rates early in the quarter," said Bjarne Bergheim, Chief Executive Offer of Sonendo. "Additionally, we recently showcased our new CleanFlow procedure instrument at the American Association of Endodontists conference in Phoenix having just announced the start of our full market release. Simpler for doctors and better for patients, our CleanFlow procedure instrument provides an opportunity for us to improve utilization while also positively changing the margin profile of our business. Lastly, on April sixth we amended our credit agreement with Perceptive Credit Holdings which provided Sonendo an additional $20 million of available credit. This amendment enhances our liquidity position, giving us the optionality needed to further support the growth of our business."

ShowHide Related Items >><<
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

SONX Sonendo
$2.78 /

+0.18 (+6.92%)

03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

  • 29
    Oct
SONX Sonendo
$2.78 /

+0.18 (+6.92%)

Hot Stocks
Sonendo rises 9.3% » 10:00
04/21/22
04/21
10:00
04/21/22
10:00
SONX

Sonendo

$3.83 /

+0.45 (+13.31%)

Sonendo is up 9.3%, or…

Sonendo is up 9.3%, or 32c to $3.75.

ShowHide Related Items >><<
SONX Sonendo
$3.83 /

+0.45 (+13.31%)

SONX Sonendo
$3.83 /

+0.45 (+13.31%)

03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
SONX Sonendo
$3.83 /

+0.45 (+13.31%)

  • 29
    Oct
SONX Sonendo
$3.83 /

+0.45 (+13.31%)

Over a quarter ago
Hot Stocks
Sonendo falls -11.5% » 12:00
03/24/22
03/24
12:00
03/24/22
12:00
SONX

Sonendo

$4.87 /

-0.58 (-10.64%)

Sonendo is down -11.5%,…

Sonendo is down -11.5%, or -63c to $4.85.

ShowHide Related Items >><<
SONX Sonendo
$4.87 /

-0.58 (-10.64%)

SONX Sonendo
$4.87 /

-0.58 (-10.64%)

03/24/22 Piper Sandler
Sonendo price target lowered to $12 from $17 at Piper Sandler
01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
SONX Sonendo
$4.87 /

-0.58 (-10.64%)

  • 29
    Oct
SONX Sonendo
$4.87 /

-0.58 (-10.64%)

Recommendations
Sonendo price target lowered to $12 from $17 at Piper Sandler » 04:58
03/24/22
03/24
04:58
03/24/22
04:58
SONX

Sonendo

$5.47 /

-0.53 (-8.83%)

Piper Sandler analyst…

Piper Sandler analyst Jason Bednar lowered the firm's price target on Sonendo to $12 from $17 and keeps an Overweight rating on the shares following the Q4 results. 2022 guidance was issued for the first time and suggests that GentleWave sales and utilization trends have started the year with good momentum despite omicron, Bednar tells investors in a research note. The analyst says Sonendo continues to be a favorite small cap idea.

ShowHide Related Items >><<
SONX Sonendo
$5.47 /

-0.53 (-8.83%)

SONX Sonendo
$5.47 /

-0.53 (-8.83%)

01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
11/23/21
Fly Intel: Top five analyst initiations
SONX Sonendo
$5.47 /

-0.53 (-8.83%)

  • 29
    Oct
SONX Sonendo
$5.47 /

-0.53 (-8.83%)

Earnings
Sonendo sees FY22 revenue $40M-$43M, consensus $41.7M  16:08
03/23/22
03/23
16:08
03/23/22
16:08
SONX

Sonendo

$5.46 /

-0.545 (-9.08%)

 
ShowHide Related Items >><<
SONX Sonendo
$5.46 /

-0.545 (-9.08%)

SONX Sonendo
$5.46 /

-0.545 (-9.08%)

01/31/22 Morgan Stanley
Sonendo initiated with an Equal Weight at Morgan Stanley
01/14/22 Piper Sandler
Piper tells small cap investors to buy basket of recent med tech IPOs
01/11/22 Piper Sandler
Piper Sandler 'strongly' recommends buying shares of Sonendo
11/23/21
Fly Intel: Top five analyst initiations
SONX Sonendo
$5.46 /

-0.545 (-9.08%)

  • 29
    Oct
SONX Sonendo
$5.46 /

-0.545 (-9.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.